Desk and the Wall
Your home screen. Every news item, filing, rule and risk event is a post you can save, share, hide, like or dislike, and the ranking learns from what you keep. A morning edition lands at 6 AM New York time with written briefs.
Tamarly Intelligence
Tamarly Intelligence is Tamarly's research platform for subscribers, covering country risk, companies, funds, sectors, markets, life sciences and digital assets, with every figure sourced and dated. It updates through the day and publishes a morning edition at 6 AM New York time.
Figures from the platform on 9 October 2026. Every figure on the platform shows its source, its date and a quality grade.
Inside the app
Twelve connected parts share one set of companies, funds, countries and sectors, so a fund links to the companies it holds, a company links to its countries and its trials, and every country page shows its market, its funds and its licensed crypto firms. Data comes from official registers and open sources, never from paid feeds.
Your home screen. Every news item, filing, rule and risk event is a post you can save, share, hide, like or dislike, and the ranking learns from what you keep. A morning edition lands at 6 AM New York time with written briefs.
Political and country risk for 218 countries: a score from 0 to 100 updated daily, 19 themes, regional views, election calendars, a United States desk and a wall of risk events under the map.
One dashboard per company: 5 years of financials, filings read with a quote for every event, ownership and insider trades, news, sentiment and its drivers, country exposure and, for drug makers, the full pipeline.
2,687 funds with holdings and fees, and 15,356 private fund managers from the SEC and EU registers, with their private funds, markets and the companies they back.
282 stock exchanges from the ISO register, 21,549 listings, indices and the funds that give access to each market, country by country.
The 22 official ISIC sections with employment, value added, emissions, rules and news, plus views investors use: energy, mining, semiconductors, defence, shipping, pharma and finance.
61,447 industry trials, every FDA drug, biologic and device decision, patents and exclusivity dates, adverse event counts, therapeutic areas and a Pipeline tab on every drug maker.
Coins and stablecoins, the 562 firms licensed or flagged under the EU's MiCA rules, and the trusts and ETFs that hold each coin, linked to every country page.
The Tamarly Research catalogue of 106 reports, read in the app, with company and country deep dives, case studies and sector reports.
Write memos and market reviews with live platform data, charts and citations. Templates include a 6-section investment memo; co-edit, comment, then export to PDF, Word or PowerPoint.
Your holdings, encrypted before they are stored, with country and sector exposure, stress tests and alerts. Fund managers run their own funds, ledgers and KPI reports.
One search across every country, company, fund, report and video, in English or French. Any page exports to PDF, Word, PowerPoint, Excel, CSV or Markdown with its sources.
Sample screens
At 6 AM New York time the morning edition refreshes the carousels and writes the day's briefs. Through the day the Wall adds filings, rules, risk events, FDA decisions and news every 15 minutes, and each post can be saved, shared or hidden.
Posts from filings, rules, risk events and news, ranked for you.
A daily score from 0 to 100 for 218 countries, with the themes behind it.
Tabs appear only when they have data.
Trials, approvals and the companies behind them.
| Date | Event | Source |
|---|---|---|
| This week | Phase 3 primary completion due | ClinicalTrials.gov |
| This month | New molecular entity approved | Drugs@FDA |
| 2031 | Last listed patent ends | Orange Book |
Documents built from live platform data.
Sample screens. Headlines on this page are illustrative.
Plans
There are 4 plans, billed monthly and cancellable at any time. Level 2 opens the full platform for $35 a month and can be tried free for 7 days; Level 3 adds every catalogue report, Digital Assets and the investment memo builder.
The Tamarly Newsletter and public pages.
Monthly reports and the research pages, including Life Sciences.
Level 1 plus the Desk, the Wall, the Risk Atlas, companies, funds, markets, portfolio and alerts. A 7-day trial is available.
Everything: every catalogue report, Digital Assets, the investment memo builder and the Productivity Hub without limits.
From official registers and open sources: SEC EDGAR, ESMA and FCA registers, ClinicalTrials.gov and the FDA, the World Bank, the ISO exchange register, GDELT news, Wikidata and ChEMBL, plus Tamarly Research. Every value carries its source, its date and a grade from A to D, and nothing comes from paid market data feeds.
The Wall and news refresh every 15 minutes, filings are read through the day, country scores and trials update daily, and the morning edition rewrites the carousels and briefs at 6 AM New York time. Registers of funds and licensed firms refresh weekly or monthly.
No. Tamarly Intelligence is research and information. Its AI writes summaries, briefs and memo sections from cited sources and never gives a buy or sell view; the reader decides. Life Sciences pages are market research, not clinical guidance.
Tamarly Intelligence runs at app.tamarly.ai. Sign in with Google, Microsoft or email, choose a plan, and you land on the Desk.
Tamarly Newsletter
Read by more than 6,000 professionals. Free to subscribe.
Tell us who you are and what you follow; we show the platform to teams on a short call.